| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | $146.07M | $145.24M | $146.03M | $157.07M | $209.82M |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $236.77M | $264.68M | $275.57M | $299.28M | $308.09M |
| R&D | $125.62M | $143.23M | $138.75M | $148.66M | $160.84M |
| SG&A | $105.21M | $115.44M | $131.88M | $145.40M | $143.85M |
| Operating Income | -$90.71M | -$119.44M | -$129.54M | -$142.20M | -$98.27M |
| Interest Expense | – | – | $23.82M | $25.00M | $26.05M |
| Tax Expense | $43.00K | $57.00K | $323.00K | $369.00K | $268.00K |
| Net Income | -$196.04M | -$76.42M | -$143.10M | -$165.29M | -$124.09M |
| EPS (basic) | -17.9300 | -0.6300 | -1.2500 | -2.0200 | -1.6500 |
| EPS (diluted) | -17.9300 | -0.9300 | -1.2500 | -2.0200 | -1.6500 |
| Shares (diluted) | $10.94K | $126.81K | $114.22M | $81.87M | $75.22M |